Targeting fibroblast CTHRC1 ameliorates cardiac fibrosis and dysfunction by suppressing cardiomyocyte NLRP3 inflammasome activation

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: a multidimensional approach Ventricular Remodelling ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology